Boothbay Fund Management, LLC Soma Logic, Inc. Transaction History

Boothbay Fund Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.76 - $2.83 $98,688 - $158,686	-56,073 Reduced 18.89%	240,758 $609,000
Q3 2023 Nov 14, 2023	BUY	$1.99 - $2.45 $46,583 - $57,352	23,409 Added 8.56%	296,831 $709,000
Q2 2023 Aug 14, 2023	SELL	$2.1 - $3.36 $24,656 - $39,449	-11,741 Reduced 4.12%	273,422 $631,000
Q1 2023 May 15, 2023	BUY	$2.13 - $3.6 $35,703 - $60,343	16,762 Added 6.25%	285,163 $727,000
Q4 2022 Feb 14, 2023	BUY	$2.05 - $3.47 $138,614 - $234,630	67,617 Added 33.68%	268,401 $673,000
Q3 2022 Nov 14, 2022	BUY	$0.63 - $5.47 $30,262 - $262,756	48,036 Added 31.45%	200,784 $582,000
Q2 2022 Aug 15, 2022	BUY	$4.27 - $8.26 $129,299 - $250,121	30,281 Added 24.73%	152,748 $690,000
Q1 2022 May 16, 2022	BUY	$7.07 - $11.62 $680,218 - $1.12 Million	96,212 Added 366.45%	122,467 $982,000
Q4 2021 Feb 14, 2022	BUY	$10.49 - $14.28 $46,544 - $63,360	4,437 Added 20.34%	26,255 $306,000
Q3 2021 Nov 15, 2021	BUY	$9.94 - $12.77 $216,870 - $278,615	21,818 New	21,818 $270,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.